Pfizer and BioNTech to develop mRNA-based shingles jab
BERLIN, Jan 5, 2022 (AFP) – Germany’s BioNTech and US pharma giant Pfizer, which partnered up to develop a Covid-19 vaccine in record time, said Wednesday they are working on a shingles vaccine using the same breakthrough mRNA technology. The companies have signed a partnership deal and are aiming for clinical trials to start in the … Read more